Artificial Intelligence (AI) Takes a Giant Leap Forward With Blockchain Infusion - Seite 2

"With Mauricio Lara spear-heading Tokenize-IT and Pablo Gonzalez directing GBT Technologies, we are certain that only a powerful outcome will come from this joint venture as they both have vast experience in the blockchain space from an operability standpoint but also from a legal, baking and public markets point of view, having been speakers in multiple conferences and a reference point in many Latin American markets" stated Mansour Khatib, CEO of Gopher. "Just yesterday at MoneConf in Dublin, the CEO of Circle Internet Financial, Inc. stated that 'We Are at the Beginning of Tokenization of Everything' (https://cointelegraph.com/news/circle-ceo-at-moneyconf-dublin-we-are-at-the-beginning-of-tokenization-of-everything ). I believe Gopher is entering the industry at the right time equipped with the right technology and personnel" added Mr. Khatib. Read this and more news for GOPH at http://www.marketnewsupdates.com/news/goph.html

Other recent and current developments in the tech industry include:

NVIDIA Corporation (NASDAQ:NVDA) recently announced the availability of NVIDIA® Isaac™, a new platform to power the next generation of autonomous machines, bringing artificial intelligence capabilities to robots for manufacturing, logistics, agriculture, construction and many other industries. Launched at Computex 2018 by NVIDIA founder and CEO Jensen Huang, NVIDIA Isaac includes new hardware, software and a virtual-world robot simulator. "AI is the most powerful technology force of our time," said Huang. "Its first phase will enable new levels of software automation that boost productivity in many industries. Next, AI, in combination with sensors and actuators, will be the brain of a new generation of autonomous machines. Someday, there will be billions of intelligent machines in manufacturing, home delivery, warehouse logistics and much more."

Intel Corporation (NASDAQ:INTC) recently announced a collaboration with Institut Curie to develop, use and implement innovative bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings. Precision medicine for cancer requires the delivery of individually adapted medical care based on the genetic characteristics of each patient. The last decade witnessed the development of high-throughput technologies such as next-generation sequencing, which paved their way in the field of oncology. While the cost of these technologies decreases, we are facing an exponential increase in the amount of data produced. In order to open access to precision medicine-based therapies to more patients, healthcare providers have to rationalize both their data production and utilization. This requires the implementation of cutting-edge technologies: high-performance computing and artificial intelligence (AI).